24016-11-3

Basic information

• Product Name: N-benzyl-3-benzyloxy-2-pyridone
• Synonyms: N-benzyl-3-benzyloxy-2-pyridone;3-(Phenylmethoxy)-1-(phenylmethyl)pyridin-2(1H)-one
• CAS NO: 24016-11-3
• Molecular Formula: C₁₉H₁₇NO₂
• Molecular Weight: 291.34378
• EINECS: 245-984-4
• Mol File: 24016-11-3.mol
• Article Data: 3

Chemical Properties

• Melting Point: 113-116℃
• Boiling Point: 530.9°Cat760mmHg
• Flash Point: 274.9°C
• Appearance: /
• Density: 1.2g/cm³
• Vapor Pressure: 2.36E-11mmHg at 25°C
• Refractive Index: 1.639
• CAS DataBase Reference: N-benzyl-3-benzyloxy-2-pyridone(CAS DataBase Reference)
• NIST Chemistry Reference: N-benzyl-3-benzyloxy-2-pyridone(24016-11-3)
• EPA Substance Registry System: N-benzyl-3-benzyloxy-2-pyridone(24016-11-3)

Safety Data

• Safety Statements: S24/25:Avoid contact with skin and eyes.
• Hazardous Substances Data: 24016-11-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C19H17NO2/c21-19-18(22-15-17-10-5-2-6-11-17)12-7-13-20(19)14-16-8-3-1-4-9-16/h1-13H,14-15H2

Upstream product

• 84719-32-4 3-Hydroxy-2(1H)-pyridinone 
• 100-44-7 benzyl chloride 
• 16867-04-2 dihydroxypyridine 
• 100-39-0 benzyl bromide 

Downstream Products

• 89847-74-5 1,4-etheno-2-benzyl-3-oxo-4-benzyloxy-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 89847-70-1 1,4-etheno-2-benzyl-3-oxo-4-benzyloxy-1,2,3,4-tetrahydroisoquinoline 
• 102249-82-1 1,4-ethano-2-benzyl-3-oxo-4-benzyloxy-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline 
• 102249-86-5 1,4-ethano-2-benzyl-4-benzyloxy-1,2,3,4-tetrahydroisoquinoline 
• 89847-75-6 1,4-ethano-2-benzyl-3-oxo-4-benzyloxy-1,2,3,4-tetrahydroisoquinoline 

Relevant articles and documents

N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors

N-Benzyl-dihydroxypyridine carboxamide compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dihydroxypyridine carboxamides are of Formula (I) wherein Q is Formula (II) or Formula (III); T is Formula (IV); and R1, R2, X1,X2,X3, and Y1 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

The synthesis of 1,4-ethano-1,2,3,4-tetrahydroisoquinolines as rigid analogues of adrenergic agents

-